|
業務類別
|
-- |
|
業務概覽
|
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123. |
| 公司地址
| 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004 |
| 電話號碼
| +81 352057200 |
| 傳真號碼
| +81 352057182 |
| 公司網頁
| https://www.kyowakirin.com |
| 員工數量
| 5669 |
| Mr. Takeyoshi Yamashita |
Director, Chief Medical Officer and Senior Managing Executive Officer |
-- |
11/03/2025 |
| Mr. Masashi Miyamoto |
Director, President and Chief Executive Officer |
-- |
11/03/2025 |
| Mr. Yutaka Osawa |
Director and Chief Compliance Officer |
-- |
11/03/2025 |
|
|
| Ms. Rumiko Nakata |
Independent Director |
11/03/2025 |
| Mr. Takashi Oyamada |
Independent Director |
11/03/2025 |
| Mr. Shinjiro Akieda |
Director |
11/03/2025 |
| Mr. Yoshihisa Suzuki |
Independent Director |
11/03/2025 |
| Mr. Takeyoshi Yamashita |
Director, Chief Medical Officer and Senior Managing Executive Officer |
11/03/2025 |
| Ms. Yuko Haga |
Independent Director |
11/03/2025 |
| Mr. Masashi Miyamoto |
Director, President and Chief Executive Officer |
11/03/2025 |
| Mr. Yutaka Osawa |
Director and Chief Compliance Officer |
11/03/2025 |
| Mr. Akira Morita |
Independent Director |
11/03/2025 |
|
|
|
|
